Suchergebnisse - "Ellis, Matthew"

PubPharm (74)

1

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination : A Phase 3 Randomized Clinical Trial

enthalten in: JAMA oncology | 2024

von Ma, C. | Suman, V. | Sanati, S. | +27

2

Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor-positive Breast Cancers for Targeted Treatment

enthalten in: Cancer research communications | 2023

von Kim, B. | Zheng, Z. | Lei, J. | +22

3

Local-Regional Recurrence After Neoadjuvant Endocrine Therapy : Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer

enthalten in: Annals of surgical oncology | 2023

von Hunt, K. | Suman, V. | Wingate, H. | +6

4

Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer : a multi-operator and multi-institutional study

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2022

von Acs, B. | Leung, S. | Kidwell, K. | +120

5

Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Suman, V. | Du, L. | Hoskin, T. | +6

6

A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy

enthalten in: Breast cancer research and treatment | 2021

von Polley, M. | Dickler, M. | Sinnwell, J. | +9

7

Assessment of Ki67 in Breast Cancer : Updated Recommendations From the International Ki67 in Breast Cancer Working Group

enthalten in: Journal of the National Cancer Institute | 2021

von Nielsen, T. | Leung, S. | Rimm, D. | +19

8

Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer

enthalten in: Nature communications | 2021

von Punturi, N. | Seker, S. | Devarakonda, V. | +8

9

The bone microenvironment increases phenotypic plasticity of ER+ breast cancer cells

enthalten in: Developmental cell | 2021

von Bado, I. | Zhang, W. | Hu, J. | +23

CommentIn: Dev Cell. 2021 Apr 19;56(8):1077-1079. - PMID 33878297

10

Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer

enthalten in: Breast cancer research and treatment | 2021

von da Silva, L. | de Andrade, C. | Brenelli, F. | +11

1
2
3
4
5
6
7
8
Nächster »
[8]